|9 Months Ended|
Sep. 30, 2023
|Subsequent Events [Abstract]|
|SUBSEQUENT EVENT||SUBSEQUENT EVENTIn November 2023, the Company announced its planned transition to a global health and wellness company. The Company plans to expand its current hemp-based product offering to include non-CBD nutraceuticals and other plant-based food products. The Company recently executed a non-binding letter of intent to acquire a plant-based food company in Europe, providing the Company with a manufacturing and distribution foothold in the EU that will allow for leverage of the Company's key strengths and competencies. Closing of the acquisition is expected to occur before the end of 2023.|
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef